# Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels

Study · id `cardio:ct-nct00987415` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT00987415](<https://clinicaltrials.gov/study/NCT00987415>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT00987415

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 253 participants.

## Technical summary

Registry record NCT00987415. Randomized; quadruple masking; primary purpose treatment. Start 2010-05 (registry gives no type); primary completion 2013-12 (actual). Results posted on 2014-10-20.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 253 participants (enrolled count; ClinicalTrials.gov record NCT00987415, source copy `cardio:ctgov-nct00987415-2014-11-04`, retrieved 2026-10-26)
- Start date: 2010-05 (registry gives no type) (ClinicalTrials.gov record NCT00987415, source copy `cardio:ctgov-nct00987415-2014-11-04`, retrieved 2026-10-26)
- Primary completion: 2013-12 (actual) (ClinicalTrials.gov record NCT00987415, source copy `cardio:ctgov-nct00987415-2014-11-04`, retrieved 2026-10-26)
- Completion: 2014-06 (actual) (ClinicalTrials.gov record NCT00987415, source copy `cardio:ctgov-nct00987415-2014-11-04`, retrieved 2026-10-26)
- Results first posted: 2014-10-20 (ClinicalTrials.gov record NCT00987415, source copy `cardio:ctgov-nct00987415-2014-11-04`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT00987415, source copy `cardio:ctgov-nct00987415-2014-11-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct00987415-2014-11-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
- Acronym: EXACT-HF
- Condition: Heart Failure
- Condition: Elevated Serum Uric Acid
- Intervention (Drug): allopurinol
- Intervention (Drug): sugar pill
- Lead sponsor: Duke University
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Duke University (`cardio:org-duke-university`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study (`cardio:pubmed-25986447`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 9786d12308958d751e4c41bdf5583a41349d1b01023266643b8528f7fa642b19
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
